A new study revealed that semaglutide reduces kidney damage markers in chronic kidney disease patients, sparking interest in further research. The diabetes medication semaglutide, commonly known as Ozempic, benefits patients with chronic kidney damage and obesity. It reduces protein levels in their urine, lowers kidney inflammation, and decreases blood pressure. This was shown in an […]
Source link